Aggressive lymphoma 2016: revision of the WHO classification. Memo-Mag, Eur Med Oncol, vol.10, pp.248-254, 2017. ,
Aggressive Lymphomas, N Engl J Med, p.13, 2010. ,
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, vol.403, p.9, 2000. ,
,
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways, Proc Natl Acad Sci, vol.105, pp.13520-13525, 2008. ,
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma, N Engl J Med, vol.346, pp.1937-1947, 2002. ,
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma, Proc Natl Acad Sci, vol.100, pp.9991-9996, 2003. ,
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity, Blood, vol.125, pp.22-32, 2015. ,
The Biology of Human Lymphoid Malignancies Revealed by Gene Expression Profiling, Advances in Immunology, pp.87005-87006 ,
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.26, pp.116-125, 2015. ,
Constitutive Nuclear Factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells, J Exp Med, vol.194, pp.1861-1874, 2001. ,
Mutations of multiple genes cause deregulation of NF-?B in diffuse large B-cell lymphoma, Nature, vol.459, pp.717-721, 2009. ,
Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly, Mol Cell, vol.51, pp.766-779, 2013. ,
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma, Nature, vol.463, pp.88-92, 2010. ,
Malt1 ubiquitination triggers NF-?B signaling upon T-cell activation, EMBO J, vol.26, pp.4634-4645, 2007. ,
NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-B activation, Proc Natl Acad Sci, vol.105, pp.3023-3028, 2008. ,
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma, Science, vol.319, pp.1676-1679, 2008. ,
The two NF-?B activation pathways and their role in innate and adaptive immunity, TRENDS Immunol, vol.25, pp.280-288, 2004. ,
Pathogenesis of human B cell lymphomas, Annu Rev Immunol, vol.30, pp.565-610, 2012. ,
A lossof-function RNA interference screen for molecular targets in cancer, Nature, vol.441, pp.106-110, 2006. ,
The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes, Nat Rev Immunol, vol.6, pp.115-119, 2006. ,
,
, Mediates Activation of TAK1 MAPKKK by Linking TAK1 to TRAF6 in the IL1 Signal Transduction Pathway, TAB2, a Novel Adaptor Protein, vol.5, pp.649-658, 2000.
IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NF?B, J Biol Chem, vol.276, pp.41661-41667, 2001. ,
,
Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma, Blood Cancer J, vol.4, pp.183-183, 2014. ,
TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature, vol.412, pp.346-351, 2001. ,
Activation of the IB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain, p.11 ,
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma, Nat Med, vol.21, pp.922-926, 2015. ,
A multiprotein supercomplex controlling oncogenic signalling in lymphoma, Nature, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02117984
,
Analysis of the coding genome of diffuse large B-cell lymphoma, Nat Genet, vol.43, pp.830-837, 2011. ,
Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas, Cancer Res, vol.71, pp.2643-2653, 2011. ,
,
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma, Cancer Cell, vol.21, pp.723-737, 2012. ,
, Phosphorylation of CARMA1 Plays a Critical Role in T Cell Receptor-Mediated NF-?B Activation, Immunity, vol.23, pp.575-585, 2005.
The Protein Kinase C-Responsive Inhibitory Domain of CARD11 Functions in NF-B Activation To Regulate the Association of Multiple Signaling Cofactors That Differentially Depend on Bcl10 and MALT1 for Association, Mol Cell Biol, vol.28, pp.5668-5686, 2008. ,
A catalytic-independent role for the LUBAC in NF-kappaB activation upon antigen receptor engagement and in lymphoma cells, Blood, vol.123, pp.2199-2203, 2014. ,
,
Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation, Mol Syst Biol, vol.11, p.810, 2015. ,
Molecular Determinants of Scaffoldinduced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling, J Biol Chem, vol.291, pp.25921-25936, 2016. ,
Linear ubiquitin chain assembly complex coordinates late thymic T-cell differentiation and regulatory T-cell homeostasis, Nat Commun, vol.7, p.13353, 2016. ,
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms, Cancer Discov, vol.4, pp.480-493, 2014. ,
A multiprotein supercomplex controlling oncogenic signalling in lymphoma, Nature, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02117984
The regulation of protein function by multisite phosphorylation-a 25 year update, Trends Biochem Sci, vol.25, pp.596-601, 2000. ,
Phosphorylation of the CARMA1 Linker Controls NF-?B Activation, Immunity, vol.23, pp.561-574, 2005. ,
PKC? regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1, J Exp Med, vol.202, pp.1423-1431, 2005. ,
I?B kinase ?-induced phosphorylation of CARMA1 contributes to CARMA1-Bcl10-MALT1 complex formation in B cells, J Exp Med, vol.204, pp.3285-3293, 2007. ,
Ca2+/Calmodulin-Dependent Protein Kinase II Is a Modulator of CARMA1-Mediated NF-B Activation, Mol Cell Biol, vol.26, pp.5497-5508, 2006. ,
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival, Nature, vol.458, pp.92-96, 2009. ,
Negative feedback loop in T cell activation through IkappaB kinaseinduced phosphorylation and degradation of Bcl10, Proc Natl Acad Sci U S A, vol.104, pp.908-913, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00162543
Degradation of Bcl10 induced by Tcell activation negatively regulates NF-kappa B signaling, Mol Cell Biol, vol.24, pp.3860-3873, 2004. ,
Essential Role for I?B Kinase ? in Remodeling Carma1-Bcl10-Malt1 Complexes upon T Cell Activation, Mol Cell, vol.23, pp.13-23, 2006. ,
Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulindependent protein kinase II, Mol Immunol, vol.44, pp.2095-2100, 2007. ,
GSK3? modulates NF-?B activation and RelB degradation through site-specific phosphorylation of BCL10, Sci Rep, vol.8, 2018. ,
The Ca 2+dependent Phosphatase Calcineurin Controls the Formation of the Carma1-Bcl10-Malt1 Complex during T Cell Receptor-induced NF-?B Activation, Mol Cell Biol, vol.27, pp.7522-7534, 2007. ,
Dephosphorylation of Bcl-10 by calcineurin is essential for canonical NF-?B activation in Th cells, Eur J Immunol, vol.41, pp.2349-2357, 2011. ,
,
Bcl10 Controls TCR-and Fc R-Induced Actin Polymerization, J Immunol, vol.178, pp.4373-4384, 2007. ,
Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-?B induction and cytokine production, Mol Immunol, vol.59, pp.110-116, 2014. ,
CARD11 and CARD14 Are Novel Caspase Recruitment Domain (CARD)/Membrane-associated Guanylate Kinase (MAGUK) Family Members that Interact with BCL10 and Activate NF-?B, J Biol Chem, vol.276, pp.11877-11882, 2001. ,
DOI : 10.1074/jbc.m010512200
Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation: Dephosphorylation of Carma1 by PP2A, EMBO J, vol.30, pp.594-605, 2011. ,
,
Phosphorylation of CARMA1 by HPK1 is critical for NF-B activation in T cells, Proc Natl Acad Sci, vol.106, pp.14508-14513, 2009. ,
, Phosphorylation within the Protein Kinase C-Regulated Domain Down-Regulates CARMA1 Activity in Lymphocytes, J Immunol, vol.183, pp.7362-7370, 2009.
Non-Oncogene Addiction and the Stress Phenotype of Cancer Cells, Cell, vol.130, pp.986-988, 2007. ,
Oncogenic CARD11 Mutations Induce Hyperactive Signaling by Disrupting Autoinhibition by the PKC-Responsive Inhibitory Domain, Biochemistry, vol.49, pp.8240-8250, 2010. ,
Equine Herpesvirus Protein E10 Induces Membrane Recruitment and Phosphorylation of Its Cellular Homologue, Bcl-10, J Cell Biol, vol.152, pp.1115-1122, 2001. ,
The ubiquitin code, Annu Rev Biochem, vol.81, pp.203-229, 2012. ,
MAGUKcontrolled ubiquitination of CARMA1 modulates lymphocyte NF-kappaB activity, Mol Cell Biol, vol.246, pp.922-934, 2010. ,
Clustering of CARMA1 through SH3-GUK domain interactions is required for its activation of NF-kappaB signalling, Nat Commun, vol.6, p.5555, 2015. ,
cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas, J Clin Invest, vol.116, pp.174-181, 2006. ,
Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-kappaB, Immunity, vol.36, pp.947-958, 2012. ,
Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex, Proc Natl Acad Sci U S A, vol.110, pp.9433-9438, 2013. ,
Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X, J Exp Med, vol.211, pp.1947-1955, 2014. ,
Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCbeta Kinase Activity, J Immunol Baltim Md, vol.1950, pp.3438-3451, 2016. ,
COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation, EMBO Rep, vol.10, pp.642-648, 2009. ,
Negative Regulation of CARD11 ,
, Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181, Mol Cell Biol, vol.36, pp.794-808, 2015.
NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated ,
, Proc Natl Acad Sci U S A, vol.105, pp.3023-3028, 2008.
,
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma, Cancer Cell, vol.29, pp.494-507, 2016. ,
,
The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor kappaB signaling, Sci Signal, vol.6, p.79, 2013. ,
,
Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells, Proc Natl Acad Sci U S A, vol.32, pp.15247-15252, 2013. ,
Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation, EMBO J, vol.26, pp.4634-4645, 2007. ,
A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains, J Immunol Baltim Md, vol.1950, pp.7718-7728, 2009. ,
, , vol.10, p.1
, and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation, J Cell Sci, vol.123, pp.2375-2380, 2010.
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes, Mol Cell, vol.14, pp.289-301, 2004. ,
Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells, Nat Commun, vol.7, p.11292, 2016. ,
TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis, Curr Biol CB, vol.16, pp.1088-1092, 2006. ,
The protease activity of the paracaspase MALT1 is controlled by monoubiquitination, Nat Immunol, vol.14, pp.337-345, 2013. ,
, Monoubiquitination and Activity of the Paracaspase MALT1 Requires Glutamate 549 in the Dimerization Interface, PLOS ONE, vol.8, p.72051, 2013.
Probes to monitor activity of the paracaspase MALT1, Chem Biol, vol.22, pp.139-147, 2015. ,
Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma, Mol Cell, vol.6, pp.961-967, 2000. ,
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20, Nat Immunol, vol.9, pp.263-271, 2008. ,
The proteolytic activity of the paracaspase MALT1 is key in T cell activation, Nat Immunol, vol.9, pp.272-281, 2008. ,
Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation, Cell Rep, vol.9, pp.1292-1305, 2014. ,
Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity, EMBO J, vol.33, pp.2765-2781, 2014. ,
,
Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation, J Immunol, vol.194, pp.3723-3734, 2015. ,
,
MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses, PLOS ONE, vol.10, p.127083, 2015. ,
Differential requirement for Malt1 in T and B cell antigen receptor signaling, Immunity, vol.19, pp.749-758, 2003. ,
Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase, Science, vol.302, pp.1581-1584, 2003. ,
A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency, J Allergy Clin Immunol, vol.132, pp.135-146, 2013. ,
The paracaspase MALT1: biological function and potential for therapeutic inhibition, Cell Mol Life Sci CMLS, vol.73, pp.459-473, 2016. ,
Cleavage by MALT1 induces cytosolic release of A20, Biochem Biophys Res Commun, vol.400, pp.543-547, 2010. ,
TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma, Genes Chromosomes Cancer, vol.47, pp.1-7, 2008. ,
Frequent inactivation of A20 in B-cell lymphomas, Nature, vol.459, pp.712-716, 2009. ,
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas, Blood, vol.114, pp.2467-2475, 2009. ,
,
Malt1-dependent RelB cleavage promotes canonical NF-B activation in lymphocytes and lymphoma cell lines, Proc Natl Acad Sci, vol.108, pp.14596-14601, 2011. ,
,
The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-?B signalling, Nat Commun, vol.6, 2015. ,
MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-?B signaling, FEBS J, vol.283, pp.403-412, 2016. ,
The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling, J Cell Sci, vol.129, pp.1775-1780, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01311283
MALT1 Auto-Proteolysis Is Essential for NF-?B-Dependent Gene Transcription in Activated Lymphocytes, PLoS ONE, vol.9, 2014. ,
Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice, Eur J Immunol, 2018. ,
Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-kappaB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells, PloS One, vol.13, p.199779, 2018. ,
Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation, PloS One, vol.12, 2017. ,
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical, Science, vol.331, pp.468-472, 2011. ,
NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100, Mol Cell, vol.7, pp.401-409, 2001. ,
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by, Nat Commun, vol.6, p.5908, 2015. ,
T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1: CYLD is cleaved by MALT1, EMBO J, vol.30, pp.1742-1752, 2011. ,
,
Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses, J Exp Med, vol.204, pp.1475-1485, 2007. ,
Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation, Nat Immunol, vol.153, pp.1079-1089, 2013. ,
The I?B kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1, Nat Immunol, vol.12, pp.692-705, 2011. ,
T cell receptordependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10, Sci Signal, vol.7, p.55, 2014. ,
,
Germline hypomorphic CARD11 mutations in severe atopic disease, Nat Genet, vol.49, pp.1192-1201, 2017. ,
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells, J Exp Med, vol.206, pp.2313-2320, 2009. ,
Essential role of MALT1 protease activity in activated B cell-like diffuse large, Proc Natl Acad Sci U S A, vol.106, pp.19946-19951, 2009. ,
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma, Proc Natl Acad Sci, vol.106, pp.19946-19951, 2009. ,
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo, Cancer Cell, vol.22, pp.812-824, 2012. ,
Molecular basis of USP7 inhibition by selective small-molecule inhibitors, Nature, vol.550, pp.481-486, 2017. ,
,
USP7 small-molecule inhibitors interfere with ubiquitin binding, Nature, vol.550, pp.534-538, 2017. ,
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9, Nature, vol.533, pp.125-129, 2016. ,
Genome engineering using the CRISPRCas9 system, Nat Protoc, vol.8, pp.2281-2308, 2013. ,
A Programmable Dual-RNAGuided DNA Endonuclease in Adaptive Bacterial Immunity, Science, vol.337, pp.816-821, 2012. ,
The CBM-opathiesA Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11BCL10-MALT1 Complex, Front Immunol, vol.9, p.2078, 2018. ,